Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney

Nicholas A Maksimowski1, Xuewen Song2, Eun Hui Bae3

  • 1Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada.

Insights

Follistatin-like-1 (FSTL1) is a key factor in chronic kidney disease (CKD) progression. This study links FSTL1 to kidney damage and disease advancement in both mouse models and human patients.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Chronic kidney disease (CKD) progression mechanisms remain incompletely understood.
  • Follistatin-like-1 (FSTL1) was identified as a significantly overexpressed gene in a mouse model of progressive nephropathy.
  • FSTL1 receptors (Tlr4, Dip2a) were upregulated in kidney injury models.

Purpose of the Study:

  • To investigate the role of Follistatin-like-1 (FSTL1) in the progression of chronic kidney disease (CKD).
  • To determine the cellular localization and functional impact of FSTL1 in kidney cells.
  • To assess the association of FSTL1 with clinical parameters and disease progression in human kidney diseases.

Main Methods:

  • Microarray analysis in *Col4a3* mice and unilateral ureteral obstruction (UUO) models.
  • RNAscope in situ hybridization and in silico analysis of human kidney single-cell transcriptomics.
  • In vitro studies using cultured kidney cells to assess FSTL1 signaling pathways and gene expression.
  • Analysis of the NEPTUNE cohort for correlations between FSTL1 levels and clinical outcomes in FSGS, MN, and IgAN.

Main Results:

  • FSTL1 was significantly overexpressed early in a mouse model of progressive kidney disease.
  • FSTL1 was localized to interstitial fibroblasts/myofibroblasts in mouse and human kidneys.
  • In vitro, FSTL1 activated AP1 and NFκB, increased collagen and IL6 expression, and induced apoptosis.
  • In human patients, FSTL1 expression correlated with age, eGFR, proteinuria, and interstitial fibrosis.
  • High baseline FSTL1 levels were associated with greater clinical CKD progression.

Conclusions:

  • Follistatin-like-1 (FSTL1) is a fibroblast-derived cytokine implicated in experimental and clinical CKD progression.
  • FSTL1 signaling pathways contribute to kidney fibrosis and inflammation.
  • FSTL1 serves as a potential biomarker and therapeutic target for managing CKD progression.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
220
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
171
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
142
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
272
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.9K